Dr.Bru mentions that the article is Regulation of neutrophilia by granulocyte colony-stimulating factor: a new cancer therapy that reversed a case of terminal hepatocarcinoma
in the Journal of Clinical Research.
He says that this kind of therapy opens very promising horizons for the treatment of all types of solid tumors in a relatively short time, since all these tumors share a common mechanism.
He also adds:
The proposed treatment is in an experimental phase, and much broader experimentation is necessary before validating it.
Therefore, at this time, there is no treatment protocol that would allow it to be used in a general way
Since it is impossible to answer to all the calls received at the Universidad Complutense de Madrid, and taking into account the disruption that these represent to normal teaching and research activities, please direct all enquiries to this email address (which you can find in the link at the beggining of this reply)
Slashdot Mirror
There is a note (in spanish) in the Complutense web site about this. http://www.ucm.es/info/ucmp/pags.php?tp=Importante %20logro%20cient%EDfico&a=directorio&d=0003499.php
I'll translate (freely) some points below:
Dr.Bru mentions that the article is
Regulation of neutrophilia by granulocyte colony-stimulating factor: a new cancer therapy that reversed a case of terminal hepatocarcinoma
in the Journal of Clinical Research.
He says that this kind of therapy opens very promising horizons for the treatment of all types of solid tumors in a relatively short time, since all these tumors share a common mechanism.
He also adds: